Linnaeus University, School of Natural Sciences, Kalmar, Sweden.
Altern Lab Anim. 2013 Mar;41(1):91-110. doi: 10.1177/026119291304100110.
Chemical regulation allows non-in vivo testing (i.e. in silico-derived and in vitro-derived) information to replace experimental values from in vivo studies in hazard and risk assessments. Although non-in vitro testing information on chemical activities or properties is subject to added uncertainty as compared to in vivo testing information, this uncertainty is commonly not (fully) taken into account. Considering uncertainty in predictions from quantitative structure-activity relationships (QSARs), which are a form of non-in vivo testing information, may improve the way that QSARs support chemical safety assessment under the EU Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) system. We argue that it is useful to consider uncertainty in QSAR predictions, as it: a) supports rational decision-making; b) facilitates cautious risk management; c) informs uncertainty analysis in probabilistic risk assessment; d) may aid the evaluation of QSAR predictions in weight-of-evidence approaches; and e) provides a probabilistic model to verify the experimental data used in risk assessment. The discussion is illustrated by using case studies of QSAR integrated hazard and risk assessment from the EU-financed CADASTER project.
化学监管允许非体内测试(即基于计算机模拟和体外实验的信息)替代体内研究的实验数据,用于危害和风险评估。虽然与体内测试信息相比,化学活性或性质的非体外测试信息存在更大的不确定性,但这种不确定性通常未(完全)被考虑在内。考虑定量构效关系(QSAR)预测中的不确定性,QSAR 是一种非体内测试信息,可能会改进 QSAR 在欧盟化学品注册、评估、授权和限制(REACH)制度下支持化学品安全评估的方式。我们认为,考虑 QSAR 预测中的不确定性是有用的,因为它:a)支持合理的决策制定;b)促进谨慎的风险管理;c)为概率风险评估中的不确定性分析提供信息;d)有助于评估权重证据方法中的 QSAR 预测;e)提供概率模型以验证风险评估中使用的实验数据。本文通过使用欧盟资助的 CADASTER 项目中的 QSAR 综合危害和风险评估案例研究来说明这一点。